Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ImmunityBio Inc.
About IBRX
Immunitybio, Inc. is a vertically integrated, clinical-stage biotechnology company developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Using its applied science and platforms to treat cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies to reduce or eliminate the need for standard high-dose chemotherapy. Its platforms and their associated product candidates are designed to attack cancer and infectious pathogens by activating both the innate immune system, including NK cells, dendritic cells, and macrophages, as well as the adaptive immune system comprising B and T cells, in an orchestrated manner. Its platforms for the development of biologic product candidates include antibody-cytokine fusion proteins, vaccine vectors, and cell therapies. Its biologic commercial product candidate, Anktiva, is an IL-15 superagonist antibody-cytokine fusion protein.
Find out what a historical investment in ImmunityBio Inc. would be worth today using our IBRX stock calculator.
Market Capitalisation
$8.35B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
11.35M
High today
$8.14
Low today
$7.81
Open price
$8.05
52-week high
$12.43
52-week low
$1.95
Ready to start your investing journey with Stake?
Open an accountHow do I buy IBRX shares in Australia?
Buying IBRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ImmunityBio Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IBRX
What is the ticker symbol of ImmunityBio Inc.?
The ticker symbol for ImmunityBio Inc. is IBRX.
How much is one share of IBRX?
One share of IBRX is valued at $7.95 as of 17 May 2026.
What is the market capitalisation of ImmunityBio Inc. IBRX?
As of 17 May 2026 ImmunityBio Inc. has a market cap of $8.35B.
What is the 52-week high for ImmunityBio Inc. stock?
The ImmunityBio Inc. 52-week high stock price is $12.43.
What is the 52-week low for ImmunityBio Inc. stock?
The ImmunityBio Inc. 52-week low stock price is $1.95.
Can I buy IBRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IBRX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IBRX on Stake
- Buy IBRX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of IBRX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
IBRX related stocks